Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2 - Positive breast cancer?

2015-03-01

Journal of Clinical Oncology , Volume 33 - Issue 7 p. 673- 675

Additional Metadata
Persistent URL	doi.org/10.1200/JCO.2014.59.5058, hdl.handle.net/1765/87013
Journal	Journal of Clinical Oncology
Organisation	Erasmus MC Cancer Institute
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Foekens, J., Martens, J. W. M., & Sleijfer, S. (2015). Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2 - Positive breast cancer?. Journal of Clinical Oncology, 33(7), 673–675. doi:10.1200/JCO.2014.59.5058

Publication